| Offering Information |
| Expected Date | - |
| Proposed Exchange/Ticker |
NYSE: DJO |
| Security Type |
Common Stock |
| Lead Underwriter |
Goldman Sachs & Co |
| Days In Registration |
82 |
| Date Filed |
24-Aug-2001 |
| Form Filed | S-1 |
Fundamentals
(Year Ending December 2007) |
| Industry |
Manufacturing |
| Business Description |
Manufacture and wholesale non operative orthopedic rehabilitation and regeneration products |
| Revenue |
$169.2M |
| Net Income |
$59.3M |
| Shares Outstanding (post-offering) |
17.86M |
| President & CEO |
LESLIE H. CROSS |
| Number of Employees |
1130 |
|
| Original Filing Information |
| US |
| Shares Filed |
- |
| Secondary Shares Filed | - |
| · As a Percent |
- |
| Primary Shares Filed |
- |
| · As a Percent |
- |
| Overallotment Shares Filed |
1350.0K |
| File Amount |
- |
| File Price Range |
$18.00 - $16.00 |
| File Mid Price |
$17.00 |
Current Filing Information
(Amended 9-Nov-2001) |
|
US |
|
Shares Filed |
9.0M |
| Secondary Shares Filed |
1.2M |
| · As a Percent |
13.3 |
| Primary Shares Filed |
7.8M |
| · As a Percent |
86.7 |
| Overallotment Shares Filed |
- |
| File Amount |
$153.0M |
| · % Change from Original |
|
| File Price Range |
$18.00 - $16.00 |
| File Mid Price |
$17.00 |
|
